UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049365
Receipt number R000056185
Scientific Title Operative Management for Traumatic Chest Wall Injuries: A Systematic Review and Meta-analysis with Trial Sequential Analysis
Date of disclosure of the study information 2022/11/01
Last modified on 2024/05/02 11:56:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Operative management for traumatic chest wall injuries: a protocol for systematic review and meta-analysis with trial sequential analysis

Acronym

Operative Management for Traumatic Chest Wall Injuries

Scientific Title

Operative Management for Traumatic Chest Wall Injuries: A Systematic Review and Meta-analysis with Trial Sequential Analysis

Scientific Title:Acronym

Operative Management for Traumatic Chest Wall Injuries

Region

Japan


Condition

Condition

Traumatic Chest Wall Injuries

Classification by specialty

Surgery in general Chest surgery Orthopedics
Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the effectiveness and safety of operative management for traumatic chest wall injuries

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Duration of mechanical ventilation

Key secondary outcomes

All-cause mortality, pneumonia, length of ICU stay, length of hospital stay, tracheostomy, quality of life including pain, spirometry


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Papers published until October 2022. Randomised controlled trials for operative versus non-operative management for traumatic multi-rib fractures
Patients; Either flail chest wall injuries or multiple (more than 3) rib fractures.
Intervention; Operative rib fracture fixation
Comparison; Non-operative management
Outcome; The duration of mechanical ventilation, all-cause mortality, pneumonia, length of stay in ICU, length of stay in the hospital, tracheostomy, quality of life including pain, spirometry

Key exclusion criteria

1) Systematic review or meta-analysis articles, retrospective analysis, non-RCT, single prospective cohort study without a control group, case reports, repeated reports.
2) Literature of very low quality.
3) Studies with research purpose or operation type differed from those defined in this study.
4) Two investigators independently screened all titles, abstracts, and full texts for eligibility. Final inclusion will be decided after resolving discrepancies between the two investigators.

Target sample size



Research contact person

Name of lead principal investigator

1st name Kazuma
Middle name
Last name Yamakawa

Organization

Osaka Medical and Pharmaceutical University

Division name

Department of Emergency and Critical Care Medicine

Zip code

569-8686

Address

2-7 Daigakumachi, Takatsuki, Osaka, Japan

TEL

0726831221

Email

kazuma.yamakawa@ompu.ac.jp


Public contact

Name of contact person

1st name Kazuma
Middle name
Last name Yamakawa

Organization

Osaka Medical and Pharmaceutical University

Division name

Department of Emergency and Critical Care Medicine

Zip code

569-8686

Address

2-7 Daigakumachi, Takatsuki, Osaka, Japan

TEL

0726831221

Homepage URL


Email

kazuma.yamakawa@ompu.ac.jp


Sponsor or person

Institute

Osaka Medical and Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

Research grant program by the Japanese Society of Thrombosis and Haemostasis

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical and Pharmaceutical University

Address

2-7 Daigakumachi, Takatsuki, Osaka, Japan

Tel

0726831221

Email

kazuma.yamakawa@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 10 Month 31 Day

Date of IRB

2022 Year 10 Month 30 Day

Anticipated trial start date

2022 Year 11 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

Systematic searching will be performed using three databases (Pubmed, Scopus, and Cochrane).

We will additionally analyze by trial sequential analysis. If we acquire sufficient data, we will perform subgroup analysis as heterogeneity analysis (age, sex, severity of trauma, with and without mechanical ventilation and lung contusion). Also, we will perform sensitivity analysis using low RoB trials.


Management information

Registered date

2022 Year 10 Month 29 Day

Last modified on

2024 Year 05 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056185


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name